Octagon Therapeutics
Brent Cezairliyan is currently serving as the Vice President of Biology at Octagon Therapeutics since 2018. Prior to this role, Cezairliyan worked as a Research Fellow at Massachusetts General Hospital from 2008 to 2017. Cezairliyan holds a Sc.B. from Brown University and a Ph.D. from Massachusetts Institute of Technology.
This person is not in any offices
Octagon Therapeutics
Octagon is developing new medicines for autoimmune disease based on selective immunomodulation.